These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15003310)
1. Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis. Hardan I; Rothman R; Gelibter A; Cohen N; Shimoni A; Sokolovsky M; Reichart M; Ishoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L Exp Hematol; 2004 Mar; 32(3):254-60. PubMed ID: 15003310 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis. Koren-Michowitz M; Hardan I; Berghoff J; Yshoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L Cancer Lett; 2007 Oct; 255(2):307-14. PubMed ID: 17590504 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma]. Smejkalová J; Vranová V; Oltová A; Kuglík P; Filková H; Heinigová J; Kovárová L; Adam Z; Krejcí M; Pour L; Büchler T; Svobodník A; Vostrejsová S; Kalábová V; Vorlícek J; Penka M; Hájek R Cas Lek Cesk; 2005; 144(7):483-8. PubMed ID: 16161543 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
6. Detection of chromosome 13 deletions by fluorescent in situ hybridization. VanWier S; Fonseca R Methods Mol Med; 2005; 113():59-69. PubMed ID: 15968095 [TBL] [Abstract][Full Text] [Related]
7. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark. Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB; Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma. Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ; Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance. Jaksic W; Trudel S; Chang H; Trieu Y; Qi X; Mikhael J; Reece D; Chen C; Stewart AK J Clin Oncol; 2005 Oct; 23(28):7069-73. PubMed ID: 16129840 [TBL] [Abstract][Full Text] [Related]
10. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization. Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956 [TBL] [Abstract][Full Text] [Related]
11. [Detection of deletion of the long arm of chromosome 13 and translocation of immunoglobulin heavy chain gene by interphase fluorescence in situ hybridization in patients with multiple myeloma]. Sun WL; Wu YJ; Li H; Wang X; Zhuang JL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):485-90. PubMed ID: 18795626 [TBL] [Abstract][Full Text] [Related]
12. [Chromosome 13q deletion detected by interphase FISH in multiple myeloma: a study of 100 cases in China]. Li Q; Lu Y; Wang YF; Liu XP; Qi JY; Zou DH; Zhao YZ; Qiu LG Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1979-82. PubMed ID: 19950573 [TBL] [Abstract][Full Text] [Related]
13. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. Fonseca R; Harrington D; Oken MM; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Blood EA; Rajkumar SV; Kay NE; Van Ness B; Greipp PR Cancer Res; 2002 Feb; 62(3):715-20. PubMed ID: 11830525 [TBL] [Abstract][Full Text] [Related]
14. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation. Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS; Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034 [TBL] [Abstract][Full Text] [Related]
15. [The significances of 13q14 deletion for development and prognosis of multiple myeloma]. Li Q; An G; Li CW; Xu Y; Deng SH; Liu XP; Qi JY; Wang YF; Zou DH; Zhao YZ; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):217-20. PubMed ID: 21569701 [TBL] [Abstract][Full Text] [Related]
16. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma]. Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264 [TBL] [Abstract][Full Text] [Related]
17. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q. Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944 [TBL] [Abstract][Full Text] [Related]
18. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH. Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581 [TBL] [Abstract][Full Text] [Related]
19. Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation. Dascalescu CM; Callanan M; Chauvet M; Le Baccon P; Pégourié-Bandelier B; Garban F; Sotto JJ; Leroux D Bone Marrow Transplant; 1999 Apr; 23(7):687-94. PubMed ID: 10218845 [TBL] [Abstract][Full Text] [Related]
20. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma]. Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]